Aerovate Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
33.25
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
5
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.55
|
0.00
|
0.55
|
100.00%
|
|
2022-12-31
|
-0.57
|
0.00
|
0.57
|
100.00%
|
|
2022-09-30
|
-0.50
|
-0.56
|
-0.06
|
-12.00%
|
|
2022-06-30
|
-0.45
|
-0.49
|
-0.04
|
-8.89%
|
|
2022-03-31
|
-0.28
|
-0.45
|
-0.17
|
-60.71%
|
|
2021-12-31
|
-0.31
|
-0.35
|
-0.04
|
-12.90%
|
|
2021-09-30
|
-0.26
|
-0.26
|
0.00
|
0.00%
|
|
2021-06-30
|
-0.16
|
-23.80
|
-23.64
|
-14775.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.50
|
|
2021-12-31
|
-37.18
|
|
2020-12-31
|
-3.70
|
|
2019-12-31
|
-1.91
|